Dr. Carole Mitnick, co-principal investigator for the endTB project and a senior tuberculosis researcher with PIH, discusses her team's newest clinical trial--launched amidst the COVID-19 pandemic--and the promise it holds for marginalized communities.

Tatiana Therosme gathered herself for a moment before talking about a young woman, born with HIV, who battled severe depression for years because of stigmatization and mistreatment resulting from people’s perceptions of her diagnosis. The young woman's mental health care is a testament to a system that has grown to serve thousands.

PIH and Harvard Medical School have provided research mentoring and resources to more than 50 health workers in Rwanda over the past five years, working to overcome systemic barriers.

Researchers from Canada, Harvard and PIH are examining how the pandemic is affecting people's use of health services amid the global crisis, to provide vital data for national responses around the world.

PIH researchers, clinicians helped lead study that again showed new-generation TB drugs to be more effective, including for patients with additional diseases.

Clinicians at PIH-supported Butaro District Hospital provided access to vital radiotherapy at a time when none was available in the country.

Lessons from an innovative screening and isolation unit created in Sierra Leone in 2014 could inform maternity care during current outbreaks.

The shared mission that unites PIH teams around the world is evident in the stories that most caught readers' attention this year. From an Ebola survivor who’s thriving in Sierra Leone to quadruplets born at University Hospital in Mirebalais, Haiti, 2019 was a remarkable year across PIH.